THE WHAT? The Tommy Hilfiger beauty business has left The Estee Lauder Companies and entered into an exclusive licensing agreement with Give Back Beauty.
THE DETAILS As reported by Global Cosmetics News last year, the Estee Lauder Companies is winding down its Aramis & Designer Fragrances unit, with Tommy Hilfiger now joining stablemates Elie Saab, Chopard and Philipp Plein at Give Back Beauty.
Stating that there’s ‘no category off limits’ due to the brand’s flexibility, Avery Baker, President and Chief Brand Officer of Tommy Hilfiger Global highlighted that there were new launches to come in 2023.
Talking about the deal with Give Back Beauty, Baker said, “They have really grown a strength in connecting with Gen Z and with next-gen consumers, especially through digital. In terms of product capabilities, what they do extends quite far beyond just fragrance. They’re really working across the entire beauty category in products that are comprised of beauty, or home or self-care, including body and wellness. We found that portfolio approach to looking at the category more holistically as a very important and appealing aspect for the future.”
THE WHY? The agreement is said to give the brand an opportunity to rethink its strategy, and could be on track to align with the booming self-care market.
Baker continued, “For the last many years, Tommy has been predominantly present with a fragrance business. We really haven’t uncapped and unlocked the potential that we believe does exist if we think about body, hair, wellness and of course, beauty, cosmetics and skin. It’s premature for me to speak specifically in detail, but across all of those as well as home fragrance.”
Aesthetic injectable companies refer to businesses or companies that specialize in manufacturing, distributing, or providing aesthetic injectable products and services. These companies focus on developing and supplying injectable substances used for cosmetic purposes, typically administered by qualified medical professionals. Aesthetic injectable companies play a crucial role in the field of aesthetic medicine and cosmetic dermatology by offering a variety of injectable products designed to enhance facial features, reduce wrinkles, and improve overall skin appearance.
Key aspects of aesthetic injectable companies include:
-
Product Development: These companies research, develop, and manufacture aesthetic injectables such as dermal fillers, botulinum toxins (e.g., Botox), collagen stimulators, and other specialized formulations. They often innovate new products to meet evolving market demands and technological advancements.
-
Distribution and Sales: Aesthetic injectable companies distribute their products through authorized channels, including healthcare providers, medical spas, and aesthetic clinics. They may also sell directly to licensed professionals who administer these treatments.
-
Regulatory Compliance: Due to the medical nature of their products, aesthetic injectable companies adhere to strict regulatory guidelines and obtain necessary approvals from health authorities (e.g., FDA in the United States) to ensure safety, efficacy, and quality standards.
-
Training and Support: Many companies provide training and educational support to healthcare professionals on the proper use, administration techniques, and safety protocols associated with their injectable products. This ensures that practitioners can deliver treatments effectively and safely.
-
Customer Support: Aesthetic injectable companies offer customer support services to healthcare providers and consumers, addressing inquiries, providing product information, and assisting with product usage and troubleshooting.
